logo

For the Inventor, By the Inventor

Madison, WI, United States of America

Thaddeus P Pruss

USPTO Granted Patents = 10

Average Co-Inventor Count = 1.6

ph-index = 6

Forward Citations = 275(Granted Patents)


Location History:

  • Baltimore, MD (US) (1997)
  • Madison, WI (US) (1997 - 2001)

Company Filing History:

goldMedal9 out of 17 
 
Clarion Pharmaceuticals Inc.
 patents
silverMedal1 out of 1 
 
Clarion Pharmaeuticals Inc.
 patent

Years Active: 1997-2001

Loading Chart...
10 patents (USPTO):Explore Patents
1. 6177476 - Nutritional supplements for replenishing plasmalogens (2001-01-23),
2. 6022560 - Pharmaceutical compositions, novel uses, and novel form of (2000-02-08),
3. 5883084 - Treatment of respiratory diseases utilizing (1999-03-16),
4. 5827836 - Retinoid glycerol phospholipid conjugates (1998-10-27),
5. 5763423 - Pharmaceutical compositions, novel uses, and novel form of (1998-06-09),
6. 5731354 - Treatment for the inhibition of neuro-degenerative disease states (1998-03-24),
7. 5730157 - Method for treating viral infection (1998-03-24),
8. 5698537 - Method of lowering the viscosity of mucus (1997-12-16),
9. 5645849 - Hemostatic patch (1997-07-08),
10. 5643596 - Hemostatic patch (1997-07-01),

Title: The Innovations of Thaddeus P. Pruss: A Pioneer in Nutritional Supplements

Introduction

Thaddeus P. Pruss, a distinguished inventor based in Madison, WI, has made significant contributions to the field of nutritional supplements. With a remarkable portfolio of 10 patents to his name, Pruss has shown his dedication to advancing health and wellness through innovative solutions. His latest inventions showcase new methods and compositions that offer therapeutic benefits to mammals.

Latest Patents

One of Pruss's most notable patents involves a groundbreaking method for replenishing plasmalogens in mammals. This invention utilizes substantially pure monoethers of glycerols and their carboxylic acid ester derivatives to effectively replenish plasmalogens. Furthermore, he has developed pharmaceutical compositions featuring novel uses of α-Tocopherylphosphocholine and its salts. These compositions have been discovered to demonstrate antiviral, anti-fungal, anti-inflammatory properties, and are capable of blocking ultraviolet radiation. His work also includes liposome technology, which utilizes α-Tocopherylphosphocholine as a structural component of the liposome bilayer, providing methods for treating various viral and fungal infections and inflammatory disorders.

Career Highlights

Thaddeus P. Pruss has worked for reputable companies, including Clarion Pharmaceuticals Inc. and Clarion Pharmaceuticals Inc., where he leveraged his expertise to further develop cutting-edge health solutions. His consistent pursuit of innovation in the field of pharmacology underscores his dedication to improving public health.

Collaborations

Throughout his career, Pruss has collaborated with notable professionals such as Andrew C. Peterson and Parvin T. Yazdi. These partnerships have enriched his innovative processes and led to significant developments in his patented inventions.

Conclusion

Thaddeus P. Pruss stands out as a remarkable inventor whose work impacts the health and wellness industry. His patents reflect a commitment to scientific progress and address significant health challenges through innovative approaches. With a focus on nutritional supplements and pharmaceutical applications, Pruss continues to pave the way for future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…